| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.2 |